ArticleAnnals of translational medicine2022

Anlotinib suppresses lung adenocarcinoma growth via inhibiting FASN-mediated lipid metabolism.

Juan Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.